Document is current
Any future updates will be listed below
-
Authors
Edahiro, Yoko
Komatsu, Norio https://orcid.org/0000-0003-1880-9126
- License Information
-
More Information
Article History
Received: 11 June 2024
Revised: 24 October 2024
Accepted: 31 October 2024
First Online: 11 November 2024
Declarations
:
: YE has received research funding from PharmaEssentia Japan KK and Meiji Seika Pharma Co., Ltd. NK serves on the board of PharmaEssentia Japan KK and has received research funding from PharmaEssentia Japan KK and Meiji Seika Pharma Co., Ltd. In addition, NK has received consulting fees from Torii Pharmaceutical Co., Ltd.
